L'Oreal says weight loss drugs affect beauty and skin care sales
L'Oreal CEO Nicolas Hieronimus stated that the rise of GLP-1 weight loss drugs is impacting beauty and skin care consumption.
L'Oreal CEO Nicolas Hieronimus stated that the rise of GLP-1 weight loss drugs is impacting beauty and skin care consumption.